EU's COVID-19 vaccine rollout suffering shortages and delays, says BioTech CEO
  • 3 years ago
The shortage is being partly blamed on the fact that the European Medicines Agency is yet to approve the Moderna and Oxford-Astrazeneca vaccines.
Recommended